Highlights and Quick Summary
- Capex/Depreciation for the quarter ending June 30, 2023 was -1.15 (a 24.79% increase compared to previous quarter)
- Year-over-year quarterly Capex/Depreciation decreased by -69.45%
- Annual Capex/Depreciation for 2022 was -0.92 (a -Infinity% decrease from previous year)
- Annual Capex/Depreciation for 2022 was 0.0 (a -100.0% decrease from previous year)
- Annual Capex/Depreciation for 2021 was -3.77 (a -Infinity% decrease from previous year)
- Twelve month Capex/Depreciation ending June 30, 2023 was -1.89 (a -14.28% decrease compared to previous quarter)
- Twelve month trailing Capex/Depreciation decreased by -49.78% year-over-year
Trailing Capex/Depreciation for the last four month:
| 30 Jun '23 | 31 Dec '22 | 31 Mar '22 | 31 Dec '21 |
|---|---|---|---|
| -1.89 | -2.2 | -3.27 | -3.76 |
Visit stockrow.com/DRTS
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Capex/Depreciation of Alpha Tau Medical Ltd.
Most recent Capex/Depreciationof DRTS including historical data for past 10 years.Interactive Chart of Capex/Depreciation of Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd. Capex/Depreciation for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | -1.15 | – | – | – | – |
| 2022 | – | – | -0.92 | -1.29 | -0.92 |
| 2021 | – | – | -3.77 | -3.71 | -3.77 |
| 2020 | – | – | 0.0 | 0.0 | -43.8 |
| 2019 | -19.59 | – | – | – | -19.59 |
Business Profile of Alpha Tau Medical Ltd.
Sector: Healthcare
Industry: Biotechnology